Detalhe da pesquisa
1.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
N Engl J Med
; 382(13): 1208-1218, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32050061
2.
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stentã- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Circ J
; 83(7): 1489-1497, 2019 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155604
3.
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.
JACC Cardiovasc Interv
; 15(11): 1153-1163, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680195
4.
Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Clin Cardiol
; 39(5): 276-84, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028303
5.
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
J Am Coll Cardiol
; 63(25 Pt A): 2805-16, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814486
6.
Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents.
Korean J Intern Med
; 28(1): 72-80, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23345999